To: twc-l@halmarax.demon.co.uk
From: Tony@halmarax.demon.co.uk (Tony Halmarack)
Subject: Re: Knock
In-Reply-To: <19960816.061031.50@halmarax.demon.co.uk>
Date: Sun, 18 Aug 1996 08:35:45 +0100
In message <19960816.061031.50@halmarax.demon.co.uk> Anexia wrote:
[...]
>Maybe everyone's decided to lurk and nobody's contributing.
It looks that way. Been a bit preoccupied lately myself, not
exactly giving TWC my all. Even so, Kevin Jones has been
offering lots of stimulating and varied ideas.
What can it be that subscribers are waiting to receive before
participating? A free pen and credit card wallet?
>Maybe nobody's got anything to say. Vacations? I dunno,
> but I wish people would start talking again.
One or two unresolved questions have arisen. Coming up
with answers to these is perhaps a little more difficult than
posing the same questions over again. I hope that someone will have the
imagination to surmount these obstacles. There hasn't been an avalanche
of offers to do the necessary research, so it looks like it might
have to be me. No harm in developing other associated threads though.
> On the short term side: What about these archives.
If it does turn out to be a short term objective, it'll be
because I (or somebody else?) get onto it in the very near future
and complete the operation PDQ.
I'm hoping to bodge something up soon. In the absence of funky
software to do the job, I may have to settle for providing an FTP site
archive which would have to be accessed by mail due to my
intermittent connection to the Net.
I'm just hoping that people don't have as much trouble using this
facility as they've had subscribing and unsubscribing to TWC.
>How does that work.
I'm glad you asked that.
> Every once in a while, I miss posts (is it politically correct in
> this anally retentive internet society to say "post" in refernce
> to a mailing list?)
I have no intention of giving out this information.
> On the long term side: What about propranolol to block the sympathomimetic
> effects of MDMA. We were discussing the use of MDMA to "prime"
> a subject's consciousness for the psychedelic experience. In fear
> that an ill person might suffer negative consequenses from the
> stimulating properties of MDMA, we were discussing ways to block
> these stimulating properties without blocking the psychotropic effects.
> Well, what about propranolol? Anybody know a sympathetic physician or
> pharmacologist that might know the definitive answer?
I've come to the conclusion that to get some of the unanswered
questions tidied up, they'll need to be addressed to other,
specialist groups. I intend to approach these groups
as a representative of the Terminal Wingding Club. This way, we
may not only get our questions answered but also attract some
relevant specialists to the list.
Glad to hear from you.
-- Tony Halmarack =(*)= Tony@halmarax.demon.co.uk